Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

The coronavirus disease-19 (COVID-19) pandemic has ravaged global healthcare with previously unseen levels of morbidity and mortality. In this study, we performed large-scale integrative multi-omics analyses of serum obtained from COVID-19 patients with the goal of uncovering novel pathogenic comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyukozkan, Mustafa, Alvarez-Mulett, Sergio, Racanelli, Alexandra C., Schmidt, Frank, Batra, Richa, Hoffman, Katherine L., Sarwath, Hina, Engelke, Rudolf, Gomez-Escobar, Luis, Simmons, Will, Benedetti, Elisa, Chetnik, Kelsey, Zhang, Guoan, Schenck, Edward, Suhre, Karsten, Choi, Justin J., Zhao, Zhen, Racine-Brzostek, Sabrina, Yang, He S., Choi, Mary E., Choi, Augustine M.K., Cho, Soo Jung, Krumsiek, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212983/
https://www.ncbi.nlm.nih.gov/pubmed/35756895
http://dx.doi.org/10.1016/j.isci.2022.104612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212983/
https://www.ncbi.nlm.nih.gov/pubmed/35756895
http://dx.doi.org/10.1016/j.isci.2022.104612

Ejemplares similares